Mesa Laboratories, Inc. (MLAB) Financials
MLAB Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2024 | 437.1 million | 281.9 million |
| Sept. 30, 2024 | 454.1 million | 292.6 million |
| June 30, 2024 | 440.4 million | 289.6 million |
| March 31, 2024 | 446.8 million | 301.4 million |
MLAB Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2024 | 17.6 million | 3.2 million |
| Sept. 30, 2024 | 3.5 million | 3.8 million |
| June 30, 2024 | 9.5 million | 2.9 million |
| March 31, 2024 | 12.3 million | 2.8 million |
MLAB Net Income
No data available :(
MLAB Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2024 | 31.0 million | 27.0 million | 15.9 million |
| Sept. 30, 2024 | 24.3 million | 118.6 million | 17.9 million |
| June 30, 2024 | 28.5 million | 214.8 million | 9.2 million |
| March 31, 2024 | 28.2 million | 228.3 million | 9.6 million |
MLAB Shares Outstanding
MLAB Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2024 | 813000 | 5.1 million | 28.9 million | 10.5 million |
| Sept. 30, 2024 | 1.8 million | 4.6 million | 27.3 million | 9.8 million |
| June 30, 2024 | 891000 | 4.7 million | 23.5 million | 10.1 million |
| March 31, 2024 | 535000 | 5.2 million | 22.6 million | 10.3 million |
MLAB Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2024 | 62.8 million | 23.1 million |
| Sept. 30, 2024 | 57.8 million | 22.4 million |
| June 30, 2024 | 58.2 million | 24.3 million |
| March 31, 2024 | 58.9 million | 27.8 million |
MLAB Revenue by Segment
MLAB
Price: $145.63
Forward Dividend Yield: 0.44%
Payout Ratio: -1.38%
Dividend Per Share: 0.64 USD
Earnings Per Share: -46.32 USD
Exchange: NMS
Sector: Technology
Industry: Scientific & Technical Instruments
Volume: 46174
Ebitda: -7.6 millionMarket Capitalization: 775.0 million
Average Dividend Frequency: 4
Years Paying Dividends: 23
DGR10: 1.01%
DGR20: 5.89%